UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 12b-25
SEC FILE NUMBER
NOTIFICATION OF LATE FILING 0-26288
FORM 10-K CUSIP NUMBER
21220B 10 5
For Period Ended: June 30, 1997
[Nothing in this form shall be construed to imply that the Commission has
verified any information contained herein.]
PART I - REGISTRANT INFORMATION
CONTOUR MEDICAL, INC.
-----------------------
Full Name of Registrant
Not Applicable
-------------------------
Former Name if Applicable
3340 Scherer Drive
--------------------------------------------------------
Address of Principal Executive Office (Street and Number)
St. Petersburg, Florida 33716
-------------------------------
City, State and Zip Code
PART II - RULES 12b-25(b) AND (c)
If the subject report could not be filed without unreasonable effort or
expense and the Registrant seeks relief pursuant to Rule 12b-25(b), the
following should be completed. (Check box if appropriate)
(a) The reasons described in reasonable detail in Part III of this form
could not be eliminated without unreasonable effort or expense;
(b) The subject annual report, semi-annual report, transition report on
Form 10-K, Form 20-F, 11-K, Form N-SAR, or portion thereof, will be
filed on or before the fifteenth calendar day following the
[X] prescribed due date; or the subject quarterly report of transition
report on Form 10-Q, or portion thereof will be filed on or before
the fifth calendar day following the prescribed due date; and
(c) The accountant's statement or other exhibit required by Rule 12b-
25 has been attached if applicable.
PART III - NARRATIVE
State below in reasonable detail the reasons why the Form 10-K, 11-K, 10-Q,
N-SAR, or the transition report or portion thereof, could not be filed within
the prescribed time period.
As previously reported in a Report on Form 8-K, on August 14, 1997 the
Company's independent auditors resigned. As a result, the Company was
required to locate and engage new independent auditors to audit the Company's
financial statements for the year ended June 30, 1997, and also reaudit the
financial statements for the year ended June 30, 1996. Due to the complexity
of the audits, the Company has been unable to provide the new auditors with
all of the information and documentation needed in sufficient time to file the
Form 10-K by the current due date.
PART IV - OTHER INFORMATION
(1) Name and telephone number of person to contact in regard to this
notification.
Jon D. Sawyer 303/893-2300
------------- -----------------------------
(Name) (Area Code)(Telephone Number)
(2) Have all other periodic reports required under Section
13 or 15(d) of the Securities Exchange Act of 1934 or
Section 30 of the Investment Company Act of 1940
during the preceding 12 months (or for such shorter)
period that the Registrant was required to file such
reports) been filed? If answer is no, identify report(s). [X]Yes [ ]No
(3) Is it anticipated that any significant change in results
of operations from the corresponding period for the last
fiscal year will be reflected by the earnings statements
to be included in the subject report or portion thereof? [X]Yes [ ]No
An explanation of the anticipated change, both narratively and
quantitatively, and, if appropriate, the reasons why a reasonable estimate of
the results cannot be made, are as follows:
Sales increased from $4,540,000 during the fiscal year ended June 30, 1996 to
approximately $54,491,000 during the fiscal year ended June 30, 1997.
Approximately $9,945,000 of the increase resulted from sales by its AmeriDyne
subsidiary, and approximatley $26,757,000 from sales by its Atlantic Medical
Supply subsidiary. The Company acquired all of the outstanding stock of
AmeriDyne effective March 1, 1996; therefore only four months of AmeriDyne's
operations were included in the financial statements for the year ended June
30, 1996. The Company acquired Atlantic Medical Supply effective July 1,
1996; therefore, no operations of Atlantic Medical Supply are included in the
Company's financial statements for the fiscal year ended June 30, 1996.
The audit of the operating statements for the fiscal year ended June 30, 1997
has not been completed and adjustments which may have a material effect on net
income may still be made. As a result, an estimate of net income for this
period is not yet available. During the fiscal year ended June 30, 1996, the
Company had net income of $527,000.
- ------------------------------------------------------------------------------
CONTOUR MEDICAL, INC.
-------------------------------------------
(Name of Registrant as Specified in Charter)
has caused this notification to be signed on its behalf by the undersigned
hereunto duly authorized.
CONTOUR MEDICAL, INC.
By:/s/ Mark W. Partin
Mark W. Partin, Vice President-Finance
Date: September 29, 1997
[ATTENTION: Intentional misstatements of omissions of fact constitute Federal
Criminal Violations (See 18 U.S.C. 1001).]